Elicio Therapeutics CFO Brian Piekos resigns effective September 6, 2024

Elicio Therapeutics, Inc.

CFO Brian Piekos notified Company of resignation on Aug 27, 2024, to pursue other opportunity.
Resignation effective September 6, 2024; no disagreement on financial reporting or accounting matters.
Company has initiated search for a new Chief Financial Officer.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Brian Piekos

Chief Financial Officer

ELTX · Elicio Therapeutics, Inc.

Effective: 2024-09-06
Filed: August 30, 2024, 7:59 PM ET

On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the “Company”), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

Brian Piekos resigned as Chief Financial Officer at Elicio Therapeutics, Inc..

Action: resigned
Role: Chief Financial Officer

Exact text from the filing

On August 27, 2024, Brian Piekos, the Chief Financial Officer and Treasurer of Elicio Therapeutics, Inc. (the “Company”), informed the Company of his intent to resign from his positions, effective September 6, 2024, to pursue another opportunity.

View on SEC.gov

Elicio Therapeutics, Inc. filing history →

Source: SEC EDGAR

accession 0001140361-24-039592

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.